|
|
Current situation and challenge of registry in China |
Yang Zhang1, Yuji Feng2, Zhi Qu1, Yali Qi3, Siyan Zhan1() |
1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing 100191, China 2. Pfizer Investment Co., Ltd., Beijing 100010, China 3. Department of Epidemiology, School of Public Health, Beihua University, Jilin 132001, China |
|
|
Abstract Increasing emphasis has been placed on registries for an organized system used in developing clinical research to improve health care. China has sufficient data that can be applied broadly, but the heterogeneity and irregularity of registries limit their applicability. This article aims to describe the status of registries in China and the related challenges. Patient registries for observational studies were retrieved from the International Clinical Trials Registry to quantitatively evaluate the number of comparatively high-quality registries in China. A literature search was also performed to provide support and updates. A total of 64 patient registries were retrieved from ClinicalTrials.gov using disease, product, and health service as criteria. The sample sizes ranged from 15 to 30 400, with only 12 registries marked as completed. This article describes and compares the detailed information in many aspects. The efficient use of registries has already made considerable progress in China; however, registries still require standardization, high-quality transition, and coordinated development.
|
Keywords
Chinese
registry study
patient registries
observational study
|
Corresponding Author(s):
Siyan Zhan
|
Online First Date: 02 September 2014
Issue Date: 09 October 2014
|
|
1 |
CD Mack, NA Dreyer, A Nancy, J Bosco, A Fabre. Using real-world evidence to inform decision making. Chin J Pharmacoepidemiol (Yao Wu Liu Xing Bing Xue Za Zhi) 2014; 23(1): 17–28 (in Chinese)
|
2 |
EM Brooke. The current and future use of registers in health information systems. Geneva: World Health Organization, 1974. Publication No.8
|
3 |
JA Churchill, HW Berendes, J Nemore. Neuropsychological deficits in children of diabetic mothers. A report from the Collaborative Sdy of Cerebral Palsy. Am J Obstet Gynecol 1969; 105(2): 257–268
pmid: 4980345
|
4 |
National Committee on Vital and Health Statistics. Frequency Asked Questions about Medical and Public Health Registries. . Accessed July 3, 2009
|
5 |
A service of the U.S. National Institutes of Health. 2014.
|
6 |
RE Gliklich, NA Dreyer. Registries for Evaluating Patient Outcomes: A User’s Guide. 2nd ed. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3.) AHRQ Publication No. 10–EHC049. Rockville, MD: Agency for Healthcare Research and Quality. September 2010
|
7 |
JL Chen, YJ Yang, JH Huang, XW Qin, SB Qiao, M Yao, HB Liu, B Xu, YJ Wu, JQ Yuan, J Chen, SJ You, J Dai, JJ Li, RL Gao. The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study. Chin J Cardiol (Zhonghua Xin Xue Guan Bing Za Zhi) 2007; 35(12): 1133–1135 (in Chinese)
pmid: 18341817
|
8 |
YM Xie, X Liao, YB Zhao, MB Li, YL Zhang, R Ma, SX Xian, J Liu, SY Li, ZH Wen, ZQ Yang, JD Zou, HS Sun, Y He, XL Li, JJ Jiang, ZF Wang, YY Li, LX Wang, YP Chang, W Yang, W Zhang. Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments). China J Chin Mater Med (Zhongguo Zhong Yao Za Zhi) 2013; 38: 2919–2924 (in Chinese)
|
9 |
E von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, JP Vandenbroucke; STROBE-Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies. Internist (Berl) 2008; 49(6): 688–693
https://doi.org/10.1007/s00108-008-2138-4
pmid: 18511988
|
10 |
D Taruscio, S Gainotti, E Mollo, L Vittozzi, F Bianchi, M Ensini, M Posada. The current situation and needs of rare disease registries in Europe. Public Health Genomics 2013; 16: 288–298
|
11 |
ML Berger, BC Martin, D Husereau, K Worley, JD Allen, W Yang, NC Quon, CD Mullins, KH Kahler. W Crown. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health 2014; 17: 143–156
|
12 |
WQ Chen, RS Zheng, HM Zeng, SW Zhang, P Zhao, J He. Trend analysis and projection of cancer incidence in China between 1989 and 2008. Chin J Oncol (Zhonghua Zhong Liu Za Zhi) 2012; 34(7): 517–524 (in Chinese)
pmid: 22967471
|
13 |
Z Dai, RS Zheng, XN Zou, SW Zhang, HM Zeng, N Li, WQ Chen. Analysis and prediction of colorectal cancer incidence trend in China. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2012; 46: 598–603 (in Chinese)
|
14 |
N Li, RS Zheng, SW Zhang, XN Zou, HM Zeng, Z Dai, WQ Chen. Analysis and prediction of breast cancer incidence trend in China. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2012; 46: 703–707 (in Chinese)
|
15 |
ST Liu, JF Wu, RS Zheng, SW Zhang, XB Sun, WQ Chen. Incidence and mortality of oralcavity and pharyngeal cancer in China, 2009. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2013; 47: 586–591 (in Chinese)
|
16 |
XO Shu, Y Zheng, H Cai, K Gu, Z Chen, W Zheng, W Lu. Soy food intake and breast cancer survival. JAMA 2009; 302(22): 2437–2443
https://doi.org/10.1001/jama.2009.1783
pmid: 19996398
|
17 |
HM Zeng, RS Zheng, SW Zhang, P Zhao, J He, WQ Chen. Trend analysis of cancer mortality in China between 1989 and 2008.Chin J Oncol (Zhonghua Zhong Liu Za Zhi) 2012; 34(7): 525–531 (in Chinese)
pmid: 22967472
|
18 |
HM Zeng, RS Zheng, SW Zhang, XN Zou, N Li, Z Dai, WQ Chen. Analysis and prediction of esophageal cancer incidence trend in China. Chin J Prev Med (Zhonghua Yu Fang Yi Xue Za Zhi) 2012; 46: 593–597 (in Chinese)
|
19 |
YJ Fan, X Song, JL Li, XM Li, B Liu, R Wang, ZM Fan, LD Wang. Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. World J Surg 2008; 32(9): 1980–1988
https://doi.org/10.1007/s00268-008-9674-x
pmid: 18566857
|
20 |
Q Gao, X Fu, JW Wei, X Chen, Y Huang, J Wang, CS Anderson, KS Wong. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) registry study. Int J Stroke 2013; 8: 150–154
|
21 |
JW Wei, EL Heeley, JG Wang, Y Huang, LK Wong, Z Li, S Heritier, H Arima, CS Anderson. Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China: the ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) registry study. Stroke 2010; 41(9): 1877–1883
https://doi.org/10.1161/STROKEAHA.110.586909
pmid: 20651267
|
22 |
JJ Li, ZW Zhang, MY Qian, YF Li, SS Wang; China Transcatheter Interventional Therapy of Congenital Heart Disease Study Group. Transcatheter interventional therapy of congenital heart disease: the results of Chinese TIT registry. Chin J Cardiol (Zhonghua Xin Xue Guan Bing Za Zhi) 2012; 40(4): 283–288 (in Chinese)
pmid: 22801304
|
23 |
PL Wang, XQ Zhao, YL Wang, ZH Yang, AX Wang, YJ Wang; China National Stroke Registry (CNSR) investigators. The impact of in-hospital pneumonia on the risk of in-hospital and long-term mortality in patients with acute ischemic stroke. Chin J Intern Med (Zhonghua Nei Ke Za Zhi) 2013; 52(7): 554–557 (in Chinese)
pmid: 24266994
|
24 |
Y Li, Z Zheng, S Hu; Chinese Coronary Artery Bypass Grafting Registry Study. The Chinese coronary artery bypass grafting registry study: analysis of the national multicentre database of 9248 patients. Heart 2009; 95(14): 1140–1144
https://doi.org/10.1136/hrt.2008.146563
pmid: 18632834
|
25 |
LJ Zhang, YD Chen, XT Song, FH Zhao, SZ Lü. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events. Chin Med J (Engl) 2009; 122(5): 502–508
pmid: 19323898
|
26 |
NA Dreyer, S Garner. Registries for robust evidence. JAMA 2009; 302(7): 790–791
https://doi.org/10.1001/jama.2009.1092
pmid: 19690313
|
27 |
RR German, LM Lee, JM Horan, RL Milstein, CA Pertowski, MN Waller; Guidelines Working Group Centers for Disease Control and Prevention (CDC). Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001; 50(RR-13): 1–35, quiz CE1–CE7
pmid: 18634202
|
28 |
D Moher, KF Schulz, D Altman; CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 2005; 1(1): 40–45
https://doi.org/10.1016/j.explore.2004.11.001
pmid: 16791967
|
29 |
LP Garrison, Jr., PJ Neumann, P Erickson, D Marshall, CD Mullins. Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health 2007;10: 326–335
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|